Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Q1 2023 13F Holders as of 31 Mar 2023

Type / Class
Equity / COMMON STOCK
Shares outstanding
25,973,289
Total 13F shares
1,200
Share change
+1,200
Total reported value
$1,668
Price per share
$1.39
Number of holders
1
Value change
+$1,668
Number of buys
1

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q1 2023

As of 31 Mar 2023 Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 1,200 shares of stock of the company.
Largest 1 holders included WR Wealth Planners, LLC.
This table shows 1 institutional shareholders of the security as of 31 Mar 2023.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.